Ocular Therapeutix, Inc. (OCUL) NASDAQ
8.33
-0.14(-1.65%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.33
-0.14(-1.65%)
Currency In USD
| Market Cap | 2.27B |
| Enterprise Value | 1.62B |
| P/E Ratio | -6.98 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 34.91 |
| Price/Book Ratio | 2.84 |
| Enterprise/Revenue | 22.2 |
| Enterprise/EBITDA | -4.62 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -5.12 |
| Operating Margin | -5.2 |
| Return On Assets | -0.33 |
| Return On Equity | -0.72 |
| Revenue | 51.82M |
| Revenue/Share | 0.23 |
| Gross Profit | 45.25M |
| EBITDA | -249.78M |
| Net Income | -265.94M |
| Diluted EPS | -1.42 |
| Total Cash | 737.06M |
| Total Cash/Share | 3.31 |
| Total Debt | 76.97M |
| Total Debt/Equity | 0.12 |
| Current Ratio | 15.39 |
| Book Value Per Share | 2.94 |
| 52-Week Change | 27.37 |
| 52-Week High | 16.44 |
| 52-Week Low | 5.8 |
| Moving Average 50 Days | 9.16 |
| Moving Average 200 Days | 11.1 |
| Average Volume | 6.31M |
| Shares Outstanding | 217.69M |
| % Held by Institutions | 102.3 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |